Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, is pleased to have supported Biogen...

Headlands Research Accelerates Growth and Diversity Commitment with the Acquisition of Multi-Site Southern California Based Artemis Institute for Clinical Research SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that it has acquired...

MolecularMD Launches Validated Tumor Mutation Burden Assay for Immuno-Oncology Clinical Trial Services PORTLAND, Ore., Aug. 22, 2018 (GLOBE NEWSWIRE) -- MolecularMD today announces it has validated Thermo Fisher Scientific’s Oncomine™ Tumor Mutation Load Assay for clinical research trials to aid...

Synergyst Research Group / Discovery Clinical Trials Honored for Second Year in a Row on the Inc. 500|5000 List of America's Fastest-Growing Private Companies New York, Nov. 6, 2012 (GLOBE NEWSWIRE) -- Synergyst Research Group / Discovery Clinical Trials have been ranked on the Inc. 500|5000 list of the fastest-growing companies in the United States for the...